Dr. Dimanthi Pliatsika

Network

ORCID digital identifier

ORCID ID: 0000-0002-1970-8995

Projects

• Evaluation of the potential of targeting the IFN1 pathway / Deputy project leader / laufend
• Evaluation of the potential of PROTACs / Deputy project leader / laufend
• Morbillivirus cell entry machinery: mechanisms, structures and antiviral drug discovery / Team member / laufend
• Platform for drug target identification / Deputy project leader / abgeschlossen

Publications

• Kalbermatter, David; Jeckelmann, Jean-Marc; Wyss, Marianne; Shrestha, Neeta; Pliatsika, Dimanthi; Riedl, Rainer; Lemmin, Thomas; Plattet, Philippe; Fotiadis, Dimitrios,

  2023.

  Structure and supramolecular organization of the canine distemper virus attachment glycoprotein.

  Proceedings of the National Academy of Sciences of the United States of America.

  120(6), pp. e2208866120.

  Available from: https://doi.org/10.1073/pnas.2208866120

• Zizzari, Alessandra Tania; Pliatsika, Dimanthi; Gall, Flavio; Fischer, Thomas; Riedl, Rainer,

  2021.

  New perspectives in oral peptide delivery.

  Drug Discovery Today.

  26(4), pp. 1097-1105.

  Available from: https://doi.org/10.1016/j.drudis.2021.01.020

Patents and patent applications

• Adams, Michael; Kemmler, Michael; Riedl, Rainer; Pliatsika, Dimanthi; Imanidis, Georgios; Herzig, Susanne; Kaiser, Marcel; Mäser, Pascal,

  2022.

  Treatment of skin disorders.

  Patent number WO2022167656 A1

  (2022-08-11)

  .

  Available from: https://worldwide.espacenet.com/patent/search?q=pn%3DWO2022167656A1

go back